Fourth report on the standardization of the one-stage prothrombin time for the control of anticoagulant therapy.

Fourth report on the standardization of the one-stage prothrombin time for the control of anticoagulant therapy. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Fourth report on the standardization of the one-stage prothrombin time for the control of anticoagulant therapy. Abstract Text:

Fourth report on the standardization of the one-stage prothrombin time for the control of anticoagulant therapy. Publishing Authors By Initials

For similar proteins: blood proteins: blood coagulation factors: thromboplastin research abstracts see: proteins: blood proteins: blood coagulation factors: thromboplastin research

PUBMED ID PMID:

MEDLINE DATE:

Fourth report on the standardization of the one-stage prothrombin time for the control of anticoagulant therapy. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Thrombosis et diathesis haemorrhagica. Supplementu

VOLUME: 35

Page Numbers: 197-208

Journal Abbreviation:

ISSN: 0040-6597

DAY: 26

MONTH: 02

YEAR: 1968

Fourth report on the standardization of the one-stage prothrombin time for the control of anticoagulant therapy. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 8106633

Fourth report on the standardization of the one-stage prothrombin time for the control of anticoagulant therapy. Keywords Mesh Terms:

KEYWORDS: Thromboplastin

MESH TERMS: standards

Chemical & Substance for Abstract: Fourth report on the standardization of the one-stage prothrombin time for the control of anticoagulant therapy. Information

Substance Name: Thromboplastin

Registry Number: 9035-58-9

Grant and Affiliation Information for Fourth report on the standardization of the one-stage prothrombin time for the control of anticoagulant therapy.

AFFILIATION:

Country: GERMANY, WEST

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Thromb Diath Haemorrh Suppl

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Fourth report on the standardization of the one-stage prothrombin time for the control of anticoagulant therapy Related Publications

• Activation of an IL-6:STAT3-dependent transcriptome in pediatric-onset inflammatory bowel disease.
• CYCLOPROPANE.
• Cigarette smoking: a child's guide to addiction.
• Criteria for a standard thromboplastin preparation.
• Fourth report on the standardization of the one-stage prothrombin time for the control of anticoagulant therapy.
• Glittering with gold therapy.
• Proposed specification for a reference thromboplastin preparation for the control of anticoagulant therapy using coumarin type drugs.
• Reaction to gold therapy.
• Second report on the standardisation of the one-stage prothrombin time for the control of anticoagulant therapy.
• Signal transducer and activator of transcription 5b promotes mucosal tolerance in pediatric Crohn's disease and murine colitis.
• Standardization of the one-stage prothrombin time for the control of anticoagulant therapy.
• The establishment and operation of a Nerve Block Clinic; one year's experience at the Los Angeles County Hospital.
• The simplified two-stage assay for Factor 8 using a combined reagent.
• Third report on the standardization of the one-stage prothrombin time for the control of anticoagulant therapy.
• Thromboplastin reference preparations.
• Tumour necrosis factor alpha blockade induces an anti-inflammatory growth hormone signalling pathway in experimental colitis.